(2,4-DICHLOROPHENYL)-N-METHYLMETHANAMINE, 95%, 25g

5,6-Dihydro-4H-cyclopenta[c]isoxazol-3-amine, 95.0%, 250mg

tert-Butyl 3-ethyl-3-hydroxyazetidine-1-carboxylate, 98%, 25g

5-Bromo-2-(bromomethyl)pyridine hydrobromide, 97.0%, 250mg

3-Sulfinobenzoic acid, 5g

Phytyl Acetate (cis- and trans- mixture)>88.0%(GC)5g

1-Methyl-3-(3-oxocyclohex-1-en-1-yl)azepan-2-one, 95%, 1g

Ethyl-(2-methoxy-pyridin-4-yl)-amine, 98%, 1g

(2E)-1-(3-chlorophenyl)-3-(2,5-dimethoxyphenyl)prop-2-en-1-one, 95.0%, 10g

3-(2-aminoethyl)-7-methyl-5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one hydrochloride, 95.0%, 250mg

Vidarabine Monohydrate>98.0%(HPLC)(T)5g

(4-Bromo-2,6-dimethylphenyl)methanamine hydrochloride, 5g

3,5-Di-tert-butyl-2-hydroxybenzaldehyde, 97.0%, 100g